[HTML][HTML] The pathophysiology of chronic thromboembolic pulmonary hypertension

G Simonneau, A Torbicki… - European Respiratory …, 2017 - Eur Respiratory Soc
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary
vascular disease that is usually a consequence of prior acute pulmonary embolism. CTEPH …

Chronic thromboembolic pulmonary hypertension: evolving therapeutic approaches for operable and inoperable disease

E Mahmud, MM Madani, NH Kim, D Poch, L Ang… - Journal of the American …, 2018 - jacc.org
Chronic thromboembolic pulmonary hypertension (CTEPH), a rare consequence of an acute
pulmonary embolism, is a disease that is underdiagnosed, and surgical pulmonary …

Epigenetic modification of the von Willebrand factor promoter drives platelet aggregation on the pulmonary endothelium in chronic thromboembolic pulmonary …

XD Manz, R Szulcek, X Pan, P Symersky… - American journal of …, 2022 - atsjournals.org
Rationale: von Willebrand factor (vWF) mediates platelet adhesion during thrombosis. While
chronic thromboembolic pulmonary hypertension (CTEPH) is associated with increased …

Evaluation and management of patients with chronic thromboembolic pulmonary hypertension-consensus statement from the ISHLT

M de Perrot, D Gopalan, D Jenkins, IM Lang… - The Journal of Heart and …, 2021 - Elsevier
ISHLT members have recognized the importance of a consensus statement on the
evaluation and management of patients with chronic thromboembolic pulmonary …

Pathophysiology and treatment of chronic thromboembolic pulmonary hypertension

N Otani, R Watanabe, T Tomoe, S Toyoda… - International Journal of …, 2023 - mdpi.com
Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition in which an
organic thrombus remains in the pulmonary artery (PA) even after receiving anticoagulation …

[HTML][HTML] Chronic thromboembolic pulmonary hypertension: a distinct disease entity

I Lang - European Respiratory Review, 2015 - Eur Respiratory Soc
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct subtype of
pulmonary hypertension (PH). One disease hypothesis is that CTEPH results from the non …

Plasma markers in pulmonary hypertension subgroups correlate with patient survival

T Koudstaal, D Van Uden, JAC Van Hulst… - Respiratory …, 2021 - Springer
Background Recent studies have provided evidence for an important contribution of the
immune system in the pathophysiology of pulmonary arterial hypertension (PAH) and …

The role of chemokines and chemokine receptors in pulmonary arterial hypertension

A Mamazhakypov, G Viswanathan… - British Journal of …, 2021 - Wiley Online Library
Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary artery
remodelling leading to increased right ventricular pressure overload, which results in right …

Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment.

NH Kim - Cardiology Clinics, 2016 - europepmc.org
Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious but treatable
complication of pulmonary embolism. Proper diagnosis and referral are critical, as …

From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension

ML Bochenek, NS Rosinus, M Lankeit… - Thrombosis and …, 2017 - thieme-connect.com
The pathomechanisms underlying the development of thrombofibrotic pulmonary artery
occlusions in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) are largely …